NRx Pharmaceuticals (NRXP) Files $150M Mixed Shelf

NRx Pharmaceuticals (NASDAQ: NRXP) has filed $150,000,000 mixed shelf of:

COMMON STOCK

PREFERRED STOCK

DEBT SECURITIES

DEPOSITARY SHARES

WARRANTS

RIGHTS

PURCHASE CONTRACTS

UNITS​

You May Also Be Interested In

• Innate Pharma licenses lacutamab to Sobi in deal worth up to $580M
• QumulusAI signs profit-sharing GPU deal with agentic hedge fund
• FDA completes first-cycle review of NRx ketamine ANDA with packaging query